dc.contributor.author |
Dey, Sangeeta |
en |
dc.contributor.author |
Menkes, David |
en |
dc.contributor.author |
Obertova, Zuzana |
en |
dc.contributor.author |
Chaudhuri, Sreemanti |
en |
dc.contributor.author |
Mellsop, Graham |
en |
dc.date.accessioned |
2018-10-23T22:54:26Z |
en |
dc.date.issued |
2016-08 |
en |
dc.identifier.issn |
1039-8562 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/43353 |
en |
dc.description.abstract |
Schizophrenia typically has a fluctuating course; rehospitalisation is common. We studied associations between discharge variables and subsequent two-year rehospitalisation rates.Using a New Zealand national database, we obtained rehospitalisation rates and bed days for 451 patients with schizophrenia discharged from three inpatient facilities between July 2009 and December 2011.Nearly half (44%) of the cohort were rehospitalised within two years. Patients over 50 were less likely [hazard ratio (HR) = 0.58, 95% confidence interval (CI) = 0.35-0.97, p = 0.04] to be rehospitalised. Patients whose index admission included compulsory treatment appeared more likely (HR = 1.3, 95% CI = 0.98-1.71, p = 0.06) to be rehospitalised and spent longer rehospitalised (p = 0.05). Those whose index admission was three weeks or longer were less likely (HR = 0.53, 95% CI = 0.39-0.72, p = 0.001) to be rehospitalised. Antipsychotic types, routes and dosages were not significantly associated with rehospitalisation rate, except for those prescribed clozapine (HR = 0.61, 95% CI = 0.41-0.89, p = 0.01).Rehospitalisation rates were higher for patients under the age of 50 and those with shorter index admissions; the latter finding requires further study. Other than the beneficial effect of clozapine, the type and route of prescribed antipsychotics did not significantly affect rehospitalisation rates. |
en |
dc.format.medium |
Print-Electronic |
en |
dc.language |
eng |
en |
dc.relation.ispartofseries |
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.subject |
Humans |
en |
dc.subject |
Clozapine |
en |
dc.subject |
Antipsychotic Agents |
en |
dc.subject |
Treatment Outcome |
en |
dc.subject |
Length of Stay |
en |
dc.subject |
Patient Readmission |
en |
dc.subject |
Regression Analysis |
en |
dc.subject |
Cohort Studies |
en |
dc.subject |
Schizophrenia |
en |
dc.subject |
Age Factors |
en |
dc.subject |
Sex Factors |
en |
dc.subject |
Databases, Factual |
en |
dc.subject |
Adolescent |
en |
dc.subject |
Adult |
en |
dc.subject |
Aged |
en |
dc.subject |
Middle Aged |
en |
dc.subject |
New Zealand |
en |
dc.subject |
Female |
en |
dc.subject |
Male |
en |
dc.subject |
Young Adult |
en |
dc.title |
Correlates of rehospitalisation in schizophrenia. |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1177/1039856216632395 |
en |
pubs.issue |
4 |
en |
pubs.begin-page |
356 |
en |
pubs.volume |
24 |
en |
dc.rights.holder |
Copyright: The author |
en |
dc.identifier.pmid |
26906441 |
en |
pubs.end-page |
359 |
en |
pubs.publication-status |
Published |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Journal Article |
en |
pubs.elements-id |
524124 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Psychological Medicine Dept |
en |
dc.identifier.eissn |
1440-1665 |
en |
pubs.record-created-at-source-date |
2016-02-25 |
en |
pubs.dimensions-id |
26906441 |
en |